Otsuka Pharmaceuti1xbet 라이브 방송l Co., Ltd.
Pharmaceuti1xbet 라이브 방송ls
February 8, 2013
7.5mg Tablets Additionally Ap1xbet 라이브 방송oved - Samsca®, Vaso1xbet 라이브 방송essin V2 Receptor Antagonist
Tokyo, Japan, February 8, 2013 - Otsuka Pharmaceuti1xbet 라이브 방송l Co., Ltd. today announced that Sams1xbet 라이브 방송® (tolvaptan), vaso1xbet 라이브 방송essin V2 receptor antagonist indicated for the treatment of volume overload in patients with heart failure, was granted additional ap1xbet 라이브 방송oval of tablets in 7.5mg dosage on February 4, 2013.
Latest Pharmaceuti1xbet 라이브 방송l Business related News Releases